Literature DB >> 2419409

Function of the CD4 and CD8 molecules on human cytotoxic T lymphocytes: regulation of T cell triggering.

B Fleischer, H Schrezenmeier, H Wagner.   

Abstract

The function of the T cell differentiation antigens CD4 (Leu-3/T4) and CD8 (Leu-2/T8) on human cytotoxic T lymphocytes (CTL) is presently seen only in conjugate formation between CTL and target cell via class II or class I MHC antigens rather than in the later killing steps. In this study, human CD4+ and CD8+ CTL clones were used to investigate the effects of monoclonal antibodies against these differentiation antigens on nonspecific triggering of cytotoxicity. Cytotoxicity was induced either by antibodies against the CD3 (T3) antigen or by the lectins Con A and PHA. Anti-CD4 or anti-CD8 antibodies specifically inhibited all types of cytotoxicity of CD4+ or CD8+ CTL, respectively, regardless of the specificity of the CTL for class I or class II HLA antigens and regardless of whether target cells expressed class I or class II antigens. These results are incompatible with an exclusive role of the CD4 and CD8 molecules in MHC class recognition and are discussed with respect to a function as negative signal receptors for these molecules on CTL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419409

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Isolation and properties of a Lyt-2.1-negative mutant of a Lyt-2.1/Lyt-2.2 CTL line.

Authors:  Z T Chu; J T Kung; C Thomas; K A Wall; P D Gottlieb
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A.

Authors:  B Fleischer; S Fleischer; K Maier; K H Wiedmann; M Sacher; H Thaler; A Vallbracht
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

3.  Distribution and functional characteristics of antigen-specific helper T cells arising after Peyer's patch immunization.

Authors:  M L Dunkley; A J Husband
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

4.  Development and characterisation of T lymphocyte lines from human small intestinal biopsies.

Authors:  D Kelleher; M F Kagnoff
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

5.  The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex.

Authors:  E K Barber; J D Dasgupta; S F Schlossman; J M Trevillyan; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.

Authors:  J Krowka; D Stites; J Mills; H Hollander; T McHugh; M Busch; L Wilhelm; L Blackwood
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

Review 7.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

8.  Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures.

Authors:  J C Beckham; D S Caldwell; B L Peterson; A M Pippen; M S Currie; F J Keefe; J B Weinberg
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

9.  T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.

Authors:  B Fleischer; H Schrezenmeier
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes.

Authors:  Q J Sattentau; J Arthos; K Deen; N Hanna; D Healey; P C Beverley; R Sweet; A Truneh
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.